REPLIMUNE GROUP, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
REPLIMUNE GROUP, INC. (REPL) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 8.59 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 8.59M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 8.22M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 8.01M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 7.89M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number as first filed |
|---|---|---|
| 2026-06-30 | 8.59M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 8.22M shares 10-K · filed 2026-06-29 | |
| 2025-12-31 | 8.01M shares 10-Q · filed 2026-02-03 | |
| 2025-09-30 | 7.89M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 7.57M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 6.70M shares 10-K · filed 2025-05-22 | |
| 2024-12-31 | 6.56M shares 10-Q · filed 2025-02-12 | |
| 2024-09-30 | 6.36M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 6.15M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 5.48M shares 10-K · filed 2024-05-16 | |
| 2023-12-31 | 5.52M shares 10-Q · filed 2024-02-08 | |
| 2023-09-30 | 5.40M shares 10-Q · filed 2023-11-07 | |
| 2023-06-30 | 5.25M shares 10-Q · filed 2023-08-03 | |
| 2022-12-31 | 4.50M shares 10-Q · filed 2023-02-09 | |
| 2022-09-30 | 4.29M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 4.14M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 4.73M shares 10-K · filed 2023-05-18 | 3.65M shares 10-K · filed 2022-05-19 |
| 2021-12-31 | 3.49M shares 10-Q · filed 2022-02-03 | |
| 2021-09-30 | 3.57M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 3.34M shares 10-Q · filed 2021-08-06 | |
| 2021-03-31 | 2.70M shares 10-K · filed 2022-05-19 | |
| 2020-12-31 | 2.62M shares 10-Q · filed 2021-02-04 | |
| 2020-09-30 | 3.89M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 2.55M shares 10-Q · filed 2020-08-07 | |
| 2020-03-31 | 2.12M shares 10-K · filed 2021-05-20 | |
| 2019-12-31 | 1.92M shares 10-Q · filed 2020-02-13 | |
| 2019-09-30 | 1.84M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 1.42M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 1.28M shares 10-K · filed 2020-06-03 | |
| 2018-12-31 | 1.15M shares 10-Q · filed 2019-02-14 | |
| 2018-09-30 | 648.48K shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 647.95K shares 10-Q · filed 2018-08-30 | |
| 2018-03-31 | 592.35K shares 10-K · filed 2019-06-28 | 592.42K shares 10-Q · filed 2018-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |